ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1946

Focused Clinical Correlation of Autoantibody Testing in Juvenile Systemic Sclerosis and Localized Scleroderma Using the Euroimmun™ Scleroderma Disease Profile

Jonathan Li1, Emily Mirizio2, Katherine Buhler3, Anne Stevens4, May Choi5, Kaila Schollaert-Fitch2, Kathryn Torok2, Christopher Liu2 and Marvin Fritzler3, 1Combined Internal Medicine-Pediatrics Residency Program, Children's Hospital of UPMC, Pittsburgh, PA, 2Pediatric Rheumatology, Children's Hospital of UPMC, Pittsburgh, PA, 3University of Calgary, Calgary, AB, Canada, 4Janssen, Hansville, WA, 5Brigham and Women's Hospital | University of Calgary, Calgary, AB, Canada

Meeting: ACR Convergence 2022

Keywords: Autoantibody(ies), Pediatric rheumatology, Scleroderma, Scleroderma, Localized, Scleroderma, Systemic

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2022

Session Title: Pediatric Rheumatology – Clinical Poster III: Other

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Commercially available autoantibody (AAb) panels are developed for adult rheumatological diseases; application to pediatric disease has not been established. As a pediatric scleroderma referral center and clinic, one of our main interests is to examine the properties of the Euroimmun™ Scleroderma Disease Profile in juvenile-onset scleroderma. These panels may be useful for prognosticating disease manifestations within juvenile systemic sclerosis (JSSc) and juvenile localized scleroderma (JLS), and therefore assisting with monitoring for specific organ manifestations.

Methods: Plasma from 42 age-matched healthy children, 60 JSSc patients, and 155 JLS patients (IRB #PRO11060222) and underwent AAb phenotyping with the Euroimmun™ (Luebeck, Germany) Scleroderma Disease Profile (line immunoassays: LIA) for 13 distinct AAbs. Pediatric cutoffs were defined as the number of standard deviations (minimum of 2) above the mean to test < 5% of pediatric control as positive. We determined AAb positivity among JSSc and JLS cohorts using these cutoffs. Chi-square analysis with significance defined as p < 0.05 was used to compare AAb profiles between cohorts and determine relationships with clinical variables.

Results: Overall 75% of JSSc patients and 33% of JLS patients were positive for at least one AAb. The most common AAbs in JSSc were Scl-70 (58%), CENP-B (22%), CENP-A (18%), and PM100 (16%). The most common AAbs in the JLS cohort were CENP-B (38%) and NOR-90 (22%). Several AAb associations with clinical features were found in JSSc and JLS (Table 1). There were some notable findings. In JSSc those with AAbs associated with overlap features, PM100 and Ro52, had more neurological disease (peripheral neuropathy), pulmonary disease (interstitial lung disease), and dermatological manifestations (vitiligo, psoriasis, sclerodactyly, calcinosis, shiny skin, Gottron’s papules/sign, heliotrope), respectively. In JLS, the RNA Polymerase III AAbs (RP11 and RP155) associated with deeper tissue involvement with lesion pain, tingling, depression and joint contractures, and CENP-A was associated with higher disease activity.

Conclusion: In one of the largest juvenile cohorts with full AAb testing, most JSSc patients had a positive AAb on the LIA Scleroderma Disease Profile specific for either Scl-70, CENP-A, CENP-B, and/or PM100, mirroring adult SSc AAb frequency. A higher frequency of centromere AAb was detected compared to prior JSSc cohort descriptions. In our cohort it was associated with a protective effect for musculoskeletal disease manifestations. JSSc patients with overlap associated AAbs had more frequent peripheral neuropathy and interstitial lung disease which could impact surveillance recommendations for these patients. In JLS, those with positive RNA Polymerase III AAbs had more frequent deep tissue involvement, which clinically may warrant more surveillance of deep tissue with modalities such as ultrasound or Magnetic resonance imaging, in addition to ensuring the involvement of physical therapy in the treatment regimen. Further investigation is required to confirm this panel’s utility in clinical practice.

Supporting image 1

Significant autoantibody associations with clinical manifestations in juvenile systemic sclerosis and juvenile localized scleroderma (p<0.05).
Bolded values are more frequent or greater for their respective AAb status.
*Dermatologic disease manifestations defined as: vitiligo, psoriasis, sclerodactyly, calcinosis, shiny skin, Gottron’s papules/sign, heliotrope.


Disclosures: J. Li, None; E. Mirizio, None; K. Buhler, None; A. Stevens, Janssen; M. Choi, AstraZeneca, MitogenDx, mallinckrodt, Janssen, AbbVie/Abbott, Alimentiv, Amgen, AVIR Pharma Inc, BioJAMP, Bristol-Myers Squibb(BMS), Celltrion, Ferring, Fresenius Kabi, McKesson, Mylan, Takeda, Pendopharm, Pfizer, Roche; K. Schollaert-Fitch, None; K. Torok, None; C. Liu, None; M. Fritzler, Mitogen Diagnostics Corporation.

To cite this abstract in AMA style:

Li J, Mirizio E, Buhler K, Stevens A, Choi M, Schollaert-Fitch K, Torok K, Liu C, Fritzler M. Focused Clinical Correlation of Autoantibody Testing in Juvenile Systemic Sclerosis and Localized Scleroderma Using the Euroimmun™ Scleroderma Disease Profile [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/focused-clinical-correlation-of-autoantibody-testing-in-juvenile-systemic-sclerosis-and-localized-scleroderma-using-the-euroimmun-scleroderma-disease-profile/. Accessed May 27, 2023.
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/focused-clinical-correlation-of-autoantibody-testing-in-juvenile-systemic-sclerosis-and-localized-scleroderma-using-the-euroimmun-scleroderma-disease-profile/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences